Biotech news, week of July 27, 2026

Reports ran between 01:00 and 09:15 UTC on Jul 27.

The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

Reported by manilatimes.net and english.aawsat.com.

Machine summary AbbVie is scheduled to report second-quarter results before the market opens on July 31, according to the source reports.

1. AbbVie will report second-quarter results before the market opens on July 31, according to the source reports.
2. According to the source reports, management gave a recent warning that one-time charges would negatively affect the upcoming earnings release.
3. The source reports state that AbbVie's pending $10.9 billion acquisition of Apogee Therapeutics was announced last month.

Reported by nasdaq.com and fool.com.

• AbbVie
• Apogee Therapeutics

Machine summary According to Royal Philips, its second-quarter comparable sales rose 4%, every segment grew, and Adjusted EBITA margin reached 16.4%; this included an effective 4.2% gain from a US tariff refund. Philips reiterated its full-year comparable sales growth outlook and increased its Adjusted EBITA and free cash flow outlook to reflect the US tariff refund, the company said.

Reported by finanznachrichten.de and medindia.net.

• Connected Care
• Royal Philips
• Diagnosis & Treatment

Full coverage: every report, when each was published, and who was named (2 outlets)

Machine summary The study appears in Nature.

1. The study appears in Nature, according to the report.
2. Responses occurred within a median of approximately three months, the report states.

Reported by Mirage News and news-medical.net.

• Nature
• Casdatifan

Reports ran from 15:00 UTC on Jul 29 to 19:30 UTC on Jul 31.

The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

Reported by iHeartRadio, orlandosentinel.com, citizensvoice.com, Daily Press, clickorlando.com, MedPage Today, Nbc Bay Area and nbcnewyork.com.

• Trump Administration
• Medicare Part D

Machine summary Australian medtech company Navi has raised $A6.8 million, according to reports. The funds are to be used to commercialise paediatric technology in the US.

1. Navi is described as an Australian medtech company.
2. Navi raised $A6.8 million, according to the reports.
3. The reports state the funds are to commercialise paediatric technology in the US.

Reported by manilatimes.net and sydneysun.com (Big News Network).

Machine summary IBBQ returned 45.5% over the past year. This analysis delves into the binary event risk and regulatory catalysts shaping IBBQ's trajectory.

1. XLV's expense ratio is 0.08% compared to IBBQ's 0.19%.
2. XLV offers a trailing-12-month dividend yield of 1.60% versus IBBQ's 0.79%.
3. IBBQ had a one-year total return of 45.5%.
4. XLV holds 60 stocks across pharmaceuticals, medical devices, healthcare providers, and life sciences tools, while IBBQ concentrates on Nasdaq-listed biotech and pharma firms.
5. XLV launched in 1998 and has a longer track record than IBBQ.

Reported by fool.com and finance.yahoo.com.

• XLV
• IBBQ

Reports ran from 20:00 UTC on Aug 2 to 09:00 UTC on Aug 3.

The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).

Reported by CNBC, finance.yahoo.com, eadt.co.uk, wharfedaleobserver.co.uk, chardandilminsternews.co.uk and yorkpress.co.uk.

• AstraZeneca
• Bristol Myers Squibb